
A new hypothermic oxygenated perfusion (HOPE S3) system was developed to mitigate risk factors in severe DCD liver grafts. The system, incorporating dual pumps and an elastic water sac to mimic cardiac functionality, was validated in rat models. Compared to earlier HOPE systems, HOPE S3 significantly reduced liver injury and improved post-transplant survival rates. This innovative approach offers a promising solution for salvaging DCD livers with severe warm ischemic injuries.
Like
Save
Share